First-Generation Cephalosporin Oral Options

Primary First-Generation Oral Cephalosporin Options

Cephalexin is widely available as a generic medication and relatively inexpensive, and is recommended in multiple guidelines for skin and soft tissue infections, urinary tract infections, and as alternative therapy for streptococcal pharyngitis, according to the American Heart Association and other guideline societies 1, 2, 3
The American Heart Association includes cephalexin as an alternative for endocarditis prophylaxis in penicillin-allergic patients, with a similar recommendation from other guideline societies 1, 4

First-generation cephalosporins, such as cephalexin, are commonly used for skin and soft tissue infections, with a recommendation from the Clinical Microbiology and Infection society 2, 5
Cephalexin is recommended as an alternative to penicillin in penicillin-allergic patients for streptococcal pharyngitis, according to the American Heart Association and other guideline societies 3
First-generation cephalosporins are used for surgical prophylaxis, according to the World Journal of Emergency Surgery 6
Cephalexin is used for endocarditis prophylaxis in specific situations, with a recommendation from the American Heart Association and other guideline societies 1, 4

Cephalosporins should not be used in patients with a history of anaphylaxis, angioedema, or urticaria with penicillins or ampicillin due to potential cross-reactivity, according to the American Heart Association and other guideline societies 1, 4
Resistance concerns: Studies have shown high resistance rates of viridans group streptococci to cephalexin, with a report from the American Heart Association and other guideline societies 4, 7

The American Academy of Pediatrics recommends cephalexin dosing for pediatric patients at 75-100 mg/kg/day divided into 3-4 doses 8
The American Heart Association advises that cephalosporins should not be used in patients with a history of anaphylaxis, angioedema, or urticaria to penicillins or ampicillin due to potential cross-reactivity 9

The European Society of Clinical Microbiology and Infectious Diseases notes that first-generation cephalosporins have a narrower spectrum than cefazolin for certain indications 10
The Infectious Diseases Society of America reports that for serious infections requiring parenteral cefazolin, oral cephalosporins are not appropriate substitutes during the acute phase 10, 11

The American College of Cardiology recommends cephalexin 2g orally as an alternative in penicillin-allergic patients for dental procedures, serving as endocarditis prophylaxis 12
Cephalexin and cefadroxil achieve cure rates of 90% or higher for streptococcal and staphylococcal skin and soft tissue infections, with comparable efficacy 13
Oral cephalexin is recommended as a switch from parenteral cefazolin when transitioning from IV to oral therapy, known as step-down therapy 14
Cephalexin is not an equivalent for severe infections requiring broad gram-negative coverage, where ceftriaxone or cefotaxime would be preferred over cefazolin 15

The American College of Cardiology warns against using cephalosporins in patients with a history of anaphylaxis, angioedema, or urticaria to penicillins or ampicillin due to potential cross-reactivity 12

Many simple boils can be managed with incision and drainage alone without systemic antibiotics, particularly if there is no surrounding cellulitis, systemic symptoms, or immunocompromise, as recommended by the Clinical Microbiology and Infection guideline 16
Consider antibiotics when there is: extensive surrounding cellulitis, fever, lymphadenopathy, multiple lesions, or in immunocompromised patients, according to the Clinical Microbiology and Infection guideline 16

If antibiotics are necessary, cephalexin is a recommended oral antibiotic for boils requiring systemic therapy, with dosing at 500 mg orally four times daily or 1000 mg twice daily for adults, and pediatric dosing at 75-100 mg/kg/day divided into 3-4 doses, although the exact citation for this dosing is not provided, the Clinical Microbiology and Infection guideline recommends considering antibiotics in certain cases 16
In MRSA-endemic areas, consider trimethoprim-sulfamethoxazole, doxycycline, or clindamycin as first-line agents, as suggested by the Clinical Microbiology and Infection guideline 16